All Candida parapsilosis articles
-
NewsRapid genomic test identifies fungal bloodstream infections
Researchers have developed a rapid genomic method that can identify fungal bloodstream infections at the species level in about seven hours. By combining host DNA depletion, whole-genome amplification and real-time nanopore sequencing, the approach could help clinicians select appropriate antifungal treatment much earlier.
-
NewsNew antiseptic capable of eliminating 99.9% of Candida parapsilosis cells
A 0.5% alcohol-based chlorhexidine antiseptic, combined with the natural organic compounds eugenol and menthol, can eliminate 99.9% of Candida parapsilosis cells. This fungus is one of the leading causes of infections in hospital settings.
-
NewsResearchers uncover hidden health risks from urban airborne microbes
Researchers have discovered that seemingly insignificant microbial components in the air, including bacteria, fungi, viruses and cellular debris, pose a long-overlooked health hazard. Bacterial endotoxins can trigger inflammatory responses in the human respiratory system in nearly 20% of cases.
-
NewsPathogenic yeast strains found in urban air but not along the coast
A pilot study has found that urban air contained pathogenic strains of Candida yeast that were absent in coastal air samples, revealing a potential transmission method.
-
NewsResearchers discover source of deadly fungal infections in bone marrow transplant patients
Scientists have found that heteroresistance is the reason a small number of transplant patients developed bloodstream infections, despite receiving prophylaxis with the antifungal drug micafungin.
-
NewsFull ICUS and abuse of meds sparked post-pandemic outbreak of drug-resistant fungus in Brazil
Researchers in Brazil have reported the largest outbreak to date of COVID-associated candidemia caused by the same drug-resistant strain of Candida parapsilosis, a fungus that invades the bloodstream and can lead to death.